Mycobacterium tuberculosis strains are differentially recognized by TLRs with an impact on the immune response by Carmona, J. A. et al.
Mycobacterium tuberculosis Strains Are Differentially
Recognized by TLRs with an Impact on the Immune
Response
Jenny Carmona1,2, Andrea Cruz1,2, Lucia Moreira-Teixeira1,2, Carole Sousa1,2, Jeremy Sousa1,2,
Nuno S. Osorio1,2, Ana L. Saraiva3, Stefan Svenson4, Gunilla Kallenius4, Jorge Pedrosa1,2,
Fernando Rodrigues1,2, Antonio G. Castro1,2*, Margarida Saraiva1,2*
1 Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal, 2 ICVS/3B’s - PT Government Associate Laboratory,
Braga/Guimara˜es, Portugal, 3 Escola Universita´ria Vasco da Gama (EUVG), Coimbra, Portugal, 4Department of Clinical Science and Education, Karolinska Institutet,
Stockholm, Sweden
Abstract
Tuberculosis associates with a wide spectrum of disease outcomes. The Beijing (Bj) lineage of Mycobacterium tuberculosis
(Mtb) is suggested to be more virulent than other Mtb lineages and prone to elicit non-protective immune responses.
However, highly heterogeneous immune responses were reported upon infection of innate immune cells with Bj strains or
stimulation with their glycolipids. Using both in vitro and in vivo mouse models of infection, we here report that the
molecular mechanism for this heterogeneity may be related to distinct TLR activations. Among this Mtb lineage, we found
strains that preferentially activate TLR2, and others that also activate TLR4. Recognition of Mtb strains by TLR4 resulted in a
distinct cytokine profile in vitro and in vivo, with specific production of type I IFN. We also uncover a novel protective role
for TLR4 activation in vivo. Thus, our findings contribute to the knowledge of the molecular basis underlying how host
innate immune cells handle different Mtb strains, in particular the intricate host-pathogen interaction with strains of the Mtb
Bj lineage.
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Introduction
Mycobacterium tuberculosis (Mtb) causes tuberculosis (TB) and is
responsible for about 2 million deaths annually [1]. One of the
most intriguing aspects of Mtb infection is the spectrum of disease
outcomes, ranging from several degrees of pathogenesis, latency or
clearance [2,3]. Various host factors, including malnutrition and
co-infection with HIV, influence on the outcome of TB [2,3].
Recently, the contribution of Mtb genetic variation to the
heterogeneity of TB outcomes is gaining importance [4]. Although
TB was thought to be caused by essentially identical bacteria,
recent evidence showed that it consists of 6 major lineages, each
associated with geographical human populations [5] and with
highly variable types of inflammatory responses [6,7]. Much
interest has been recently devoted to the study of the heterogeneity
of responses associated with the East Asian (Bejing/W) (Bj) lineage
of Mtb [8]. Several studies associate Mtb Bj strains with more
severe forms of TB, TB outbreaks, drug resistance and less
efficacious BCG vaccination [8,9,10]. Experimental infections
with Mtb Bj strains show the induction of non-uniform immune
responses [11,12,13,14,15], but the molecular bases underlying
this variability remain largely unclear.
The initiation of the immune response to Mtb relies on bacterial
sensing by pattern recognition receptors (PRRs), as TLRs,
expressed by multiple cell types including macrophages and
dendritic cells (DCs) [16,17]. Recognition of Mtb by TLRs triggers
various intracellular signaling cascades, ultimately inducing the
production of cytokines, chemokines and antimicrobial molecules
[18,19]. Evidence demonstrating a role for TLR activation in the
control of Mtb comes from studies showing a lethal infection in
mice lacking the master TLR signaling adaptor MyD88
[20,21,22]. However, the contribution of individual TLRs awaits
further clarification. TLR2 is central for in vitro activation of the
innate immune response [16], and was shown to impact the
maintenance of Th17 cells in the lung of Mtb-infected animals
[23] and granuloma formation [23,24], but not bacterial burden
[23,24,25,26]. The role of other TLRs, such as TLR4 and TLR9,
has been less addressed [25,27,28,29]. In humans, the association
of TLR polymorphisms with susceptibility to TB remains to be
confirmed/needs further studies [19]. Different polymorphisms in
the human TLR2 gene were reported to associate with increased
susceptibility to TB [30,31,32,33], whereas such association was
not observed in other studies [34,35,36,37]. Furthermore, a MAL/
TIRAP functional variant, affecting signaling through TLR2, was
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shown to be protective in TB [38]. Regarding TLR4, while genetic
polymorphisms in an Asian Indian population were linked to an
increased susceptibility and severity of pulmonary TB [39], in
Gambian, Indian or Chinese TB patients no association was found
[36,37,40]. This discrepancy might be explained on the basis of a
dynamic host-pathogen genetic and pathogen phenotypic inter-
play, as postulated from studies involving TLR2 polymorphisms
[41].
Herein we show that some Mtb strains preferentially activate
TLR2, whereas others activate TLR4. This differential recogni-
tion of Mtb strains impacts on both in vitro and in vivo immune
responses, specifically inducing the production of different arrays
of pro- and anti-inflammatory cytokines. Our findings present
evidence that differential TLR recognition evoked by different
Mtb strains may be decisive for shaping of innate immune
responses in vitro and in vivo and possibly contributing for the
outcome of Mtb infection.
Materials and Methods
Ethics Statement
All animal experiments were performed in strict accordance
with the recommendations of the European Union Directive 86/
609/EEC. This study was previously approved by the Portuguese
National Authority for Animal Health - Direcc¸a˜o Geral de Veterina´ria
(ID: DGV 594 from 1st June 2010). Mice were humanely
euthanized by cervical dislocation and every effort was made to
minimize suffering.
Animals
Eight to 12-week-old female C57BL/6 (BL6) mice, obtained
from Charles River (Barcelona, Spain), Rag22/2 from IGC,
Portugal and TLR22/2 or TLR42/2 mice, bred at ICVS, were
used.
Bacteria
H37Rv Pasteur, HN878 and 03-265 were kind gifts from P.J.
Cardona (Unitat de Tuberculosi Experimental, Barcelona), A. O’Garra
(MRC-NIMR, UK) and F. Portaels (Institute of Tropical
Medicine, Belgium), respectively. All Mtb strains were handed in
the same way. Mtb strains were grown in 7H9 liquid media for 7–
10 days and then diluted into Proskauer Beck medium with 0.05%
Tween 80 for further expansion. When in mid-log phase bacterial
stocks were frozen in 1 ml aliquots at –80uC. A few days later,
aliquots of Mtb stocks were thawed and used to control for
bacterial load. For this, serial dilutions of 6 frozen vials of each
strain were plated in 7H11 agar plates and viable bacteria (colony
forming units) counted after 3 weeks of incubation at 37uC. The
obtained value was used to calculate the concentration of each
strain stock used. All stocks were checked for Endotoxin
contamination using the limulus assay (Sigma) and found to be
negative. To infect macrophages or animals the frozen Mtb stocks
were thawed and directly diluted in cDMEM (in vitro studies) or
PBS (in vivo infections), considering the obtained value for CFU to
calculate the volume of each strain stock needed for a specific moi.
Genetic Analysis
Genomic DNA from each strain was subjected to PCR
amplification as previously described [42] to determine whether
the genomic deletions (RD105, RD181, RD150 and RD142) were
present or absent..
Culture of BMDM
Bone marrow cells from WT, TLR22/2 or TLR42/2 animals
were isolated from femurs and tibia and differentiated in the
present of LCCM as previously described [43]. On day 7, cells
were collected and infected with Mtb strains at a multiplicity of
infection (moi) of 2 or with increasing moi (from 0.5 to 5) when
indicated. At specific time-points post-infection, total RNA was
isolated or supernatants collected and cytokine expression assessed
by real-time PCR or ELISA.
Quantitative Real Time-PCR analysis
Total RNA from infected lungs or cultured BMDMs was
extracted with TRIzolH Reagent (Invitrogen) according to the
manufacturer’s instructions. cDNA was synthesized and analyzed
by real-time PCR as described previously [23]. Target gene
mRNA expression was quantified using SYBR green (Qiagen) and
specific oligonucleotides for each cytokine and normalized to the
ubiquitin mRNA levels [23].
ELISA
Supernatants from Mtb-infected BMDM cultures were screened
for TNF, IL-6, IL-12p40, IL-10, IL-1b or IFN-b using commer-
cially available kits.
Experimental Infection
Mice were anesthetized with Ketamine/Medetomidine and
infected intranasally with 100 cfu of each Mtb strain as reported
previously [23]. All animal experiments were performed according
to the European Union Directive 86/609/EEC and were
previously approved by the National Authority Direcc¸a˜o Geral de
Veterina´ria.
Bacterial Load Determination
At specific time points post-infection, mice were sacrificed and
the organs aseptically excised and homogenized in PBS. Serial
dilutions of the organ homogenate were plated on nutrient 7H11
agar. Bacterial cfu were counted after 3 weeks of incubation at
37uC.
iNOS Detection by Immunofluorescence
Caudal lobes of lungs from WT or TLR42/2 infected mice
were inflated with 3.8% phosphate-buffered formalin, fixed for 1
week and embedded in paraffin. Sections of 4mm thickness were
used to detect iNOS by immunofluorescence with a goat anti-
mouse antibody (M-19G, Santa Cruz) and detected with Alexa
Fluor 568-conjugated polyclonal rabbit anti-goat (Invitrogen).
DAPI (49,6-diamino-2-phenylindole hydrochloride) was used to
counterstain tissues and to detect nuclei.
Statistics
Data are expressed as means 6 SEM. Statistical significance
was calculated by using two-tailed Student t-test. Values of p#0.05
were considered statistically significant.
Results
M. tuberculosis Beijing Strains are Differentially
Recognized by TLR2 or TLR4
The Bj lineage of Mtb is known to induce heterogeneous
immune responses [6,7,9,11,12,13,14,15]. In the search for the
host molecular basis underlying this heterogeneity, we started by
comparing the induction of cytokine production by bone marrow-
derived macrophages (BMDM) upon stimulation with a collection
Mtb Has TLR2- and TLR4-Activating Strains
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Figure 1. Mtb strains induce heterogeneous cytokine profiles in macrophages. (A) Phylogenetic distribution of the studied Mtb strains
within the different subgroups of the Bj family defined by the presence or absence of the genomic deletions RD105, RD181, RD150, and RD142. (B)
WT BMDM were infected with the laboratory reference strain (H37Rv) or with various Mtb strains of the Bj lineage (HN878 to 02-171). Six hours post-
infection supernatants were harvested and the production of the indicated cytokines assessed by immunoassay. Each bar represents Mean6SEM of
triplicate wells in three independent experiments. bdl, below detection level. (C) WT BMDM were infected with Mtb strains H37Rv (open circles) or 02-
171 (close circles) at different moi. Six hours post-infection the supernatant of the infected cultures was harvested and the amount of secreted TNF
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of phylogenetically diverse Mtb isolates of the Bj lineage
(Figure 1A). Our analysis of cytokine production by infected cells
was performed at 6 h post-infection, in order to focus on the
events triggered by the innate immune recognition of Mtb strains,
thus minimizing autocrine effects likely to occur at later times.
Among this collection of Mtb isolates, we found strains, including
HN878, that were lower inducers of both pro- and anti-
inflammatory cytokine production than H37Rv (Figure 1B), which
is in line with previous reports [44]. However, we also found
strains that induced higher cytokine production in macrophages
than H37Rv (Figure 1B). Overall the highest cytokine amounts
were detected in macrophages infected with Mtb strain 02-171.
This strain induced significantly higher TNF production than Mtb
H37Rv at all moi tested (Figure 1C). The differences observed in
the TNF production between Mtb strains H37Rv and 02-171
were not related to specific stocks, as independent stocks prepared
by independent operators yielded the same results (Figure S1A).
Furthermore, the differences in the cytokine responses induced in
macrophages upon infection with different Mtb strains was not
due to differential infection rate or bacterial uptake (Figure S1B).
Interestingly, Mtb strain 02-171 was unique in its ability to
induce the secretion of IFN-b by macrophages (Figure 1B). To
make sure that the differences observed were not due to delays in
the kinetic profile of IFN-b production induced by Mtb strains
H37Rv or 02-171, we measured IFN-b in the supernatants of 24 h
infected macrophages and the same outcome was observed;
however, at this time point, Mtb H37Rv induced a robust
production of TNF, IL-10 and IL-1b by infected macrophages
(data not shown). Furthermore, the kinetic analysis of IFN-b
transcription upon infection of macrophages with Mtb strains,
showed that strain 02-171 induced high levels of expression,
whereas for the reference strain, H37Rv, only negligible
transcriptional induction of this gene was observed (Figure 1D).
Considering the aforementioned unique secretion of IFN-b by
macrophages infected with Mtb strain 02-171 and that TLRs are
important in the recognition of Mtb [16,19], we hypothesized that
the observed heterogeneity might be due to differential activation
of TLRs, particularly of TLR4, by Mtb isolates. To test this
hypothesis, we infected BMDM of WT, TLR22/2 and TLR42/2
origin, with the panel of Mtb Bj strains under study. Interestingly,
we found that the induction of cytokine production by macro-
phages was due, for most of the studied strains, to TLR2
activation, as expected from previous studies [19], whereas in the
case of Mtb strain 02-171 it was mostly dependent on TLR4
activation (Figure 2A). In particular, the ability of Mtb strain 02-
171 to induce the secretion of IFN-b by infected BMDM was
totally dependent of TLR4 signals (Figure 2A, bottom panel).
Kinetic mRNA analysis of WT BMDM infected with Mtb strains
H37Rv or 02-171 revealed a pattern of variation consistent with
the protein analysis (Figure S1C). The production of TNF by
macrophages infected with Mtb strain 02-171 depended on the
activation of TLR4 for all tested moi (Figure S1D). The presence
of polymyxinB (an endotoxin inhibitor), at a concentration that
inhibited over 50% of the TNF production by BMDM in response
to LPS, did not interfere with the response of BMDM infected
with Mtb strains H37Rv, HN878 or 02-171 (Figure 2B). In
addition to TLR2 and TLR4, TLR9 has also been involved in
Mtb recognition [19,25]. We tested whether Mtb strain 02-171
varied in its ability to induce TLR9 signals and found that the
contribution of this receptor to TNF induction was minimal
(Figure 2C), in line with previous reports for Mtb strain H37Rv
[25]. Recognition by TLR4 was not unique to the Mtb Bj lineage
as an isolate of the Euro-American lineage (Mtb strain Harlingen)
also triggered cytokine production in macrophages via TLR4,
including the production of IFN-b (Figure 3).
Altogether, we show that distinct Mtb isolates of the Bj lineage
are recognized by different TLRs in macrophages, resulting in the
production of singular cytokine profiles, the most striking
difference being the presence or absence of type I IFN. Thus,
we propose the differential TLR recognition of Mtb strains as a
possible molecular determinant of heterogeneous innate immune
responses to Mtb.
In vivo Analysis of Infection with M. tuberculosis TLR4-
activating 02-171 Strain
In view of the striking differences observed between the
responses of macrophages to Mtb strains H37Rv versus 02-171,
we next investigated the progression of in vivo infections with these
two strains. As compared to H37Rv, the bacterial burden in lungs
of mice infected with Mtb strain 02-171 was higher during the
initial phase of infection (up to day 21 post-infection) (Figure 4A).
However, this pulmonary load was significantly reduced between
days 21 and 30, remaining stable and becoming closer to Mtb
strain H37Rv for the duration of the experiment (up to day 150
post-infection) (Figure 4A). The increased bacterial burden
observed in the first three weeks of infection for the Mtb strain
02-171 was accompanied by enhanced lung pathology, measured
by the extent of lung infiltrates (Figure 4B). However, and as
observed for the progression of bacterial burden (Figure 4A), the
lung pathology was similar to both strains at later time points
(Figure 4B). In line with our in vitro data (Figure 1B), the expression
of cytokines at the site of infection was higher in the case of Mtb
strain 02-171 as compared to H37Rv (Figure 4C). Interestingly,
the lung expression of iNOS during infection with Mtb strain 02-
171 was also higher than with H37Rv (Figure 4C). Altogether our
data suggest that Mtb strain 02-171 may be more virulent for mice
during the innate immune phase of the infection, although the
adaptive immune response is efficient in inducing bacteriostasis.
To further investigate whether Mtb strain 02-171 is indeed more
virulent for mice than H37Rv during innate immunity, we infected
Rag22/2 mice with either strain and followed the progression of
infection. Rag22/2 mice infected with Mtb strain 02-171
succumbed earlier than H37Rv-infected ones (Figure 4D) and
showed higher bacterial burdens at day 30 post-infection
(Figure 4E). Our data thus show that Mtb strain 02-171 is more
virulent than H37Rv as evidenced by a faster bacterial replication
at early stages of infection, earlier killing of immune compromised
hosts and enhanced lung pathology. However, Mtb strain 02-171
does induce an adaptive immune response that manages to reduce
lung bacterial loads at later stages of infection.
measured by immunoassay. Each time point represents Mean6SEM of triplicate wells. (D) WT BMDM were infected with Mtb strains H37Rv (open
circles) or 02-171 (close circles) with a moi of 2 and at different time points post-infection, RNA was isolated and the expression of IFN-b determined
relatively to ubiquitin. Each time point represents Mean6SEM of triplicate wells. The statistics analysis, determined by the Student’s t-test, refers to
differences between each strain and H37Rv (*,p#0.05; **,p#0.01; ***,p#0.001). All bacterial stocks were handed in the same way, as detailed in
Materials and Methods.
doi:10.1371/journal.pone.0067277.g001
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Figure 2. Mtb strains specifically activate TLR2 or TLR4 for cytokine induction. (A) BMDM generated from WT (black bars), TLR22/2 (grey
bars) or TLR42/2 (white bars) mice were infected with various Mtb strains and cytokine secretion measured as in Figure 1B. Each bar represents
Mean6 SEM of triplicate wells in three independent experiments. bdl, below detection level. (B) WT BMDM were infected with Mtb strains H37Rv,
HN878 or 02-171 (moi of 2) or stimulated with LPS (25 ng/ml) in the absence (-) or presence (+) of polymyxin B (PMX B, 5 mg/ml). Six hours post-
infection the amount of TNF secreted by macrophages was determined by immunoassay. Each bar represents Mean6SEM of triplicate wells. (C) WT
or TLR92/2 BMDM were infected with Mtb strain 02-171 (moi of 2). Six hours post-infection the supernatant of the infected cultures was harvested
and the amount of secreted TNF measured by immunoassay. Each bar represents Mean6SEM of triplicate wells. The statistics analysis, determined by
the Student’s t-test, refers to differences between TLR22/2 or TLR42/2 and WT macrophages for each strain in (A), to differences between the
absence or presence of polymyxin B in (B) and to differences between TLR92/2 and WT macrophages in (C) (*,p#0.05; **,p#0.01; ***,p#0.001).
doi:10.1371/journal.pone.0067277.g002
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TLR4 Deficiency Impacts the Outcome of in vivo Infection
by a TLR4-activating M. tuberculosis Strain
We next sought to investigate whether the differences (Figure 4)
observed in the immune response between Mtb strains H37Rv
and 02-171 were related to the distinct activation of TLR4/TLR2
by the latter (Figure 2), by infecting BL6 WT or TLR42/2 mice
with either strain. Whilst absence of TLR4 did not impact the
growth of Mtb strain H37Rv in mice, lack of this receptor led to a
marked increase in the lung bacterial burden of Mtb strain 02-
171-infected mice within the first two weeks post-infection
(Figure 5A). After day 18 post-infection, when the acquired
immune responses take control [45,46], growth of Mtb strain 02-
171 strain was controlled even in the absence of TLR4 (Figure 5A).
However, the bacterial burdens remained higher in TLR42/2
than in WT mice and higher than the ones found in mice infected
with H37Rv (Figure 5A). Of note, absence of TLR2 was
dispensable for bacterial control during infections with either
Mtb H37Rv or 02-171 strains (Figure S2A).
In line with a role for TLR4 in the in vitro recognition of Mtb
strain 02-171 (Figure 2A), the absence of this TLR led to a marked
reduction in the expression of several cytokines in infected lungs
(Figure 5B). Indeed, in TLR42/2 infected lungs the level of
cytokine expression induced by Mtb strain 02-171 was very much
similar to that observed upon infection of WT mice with H37Rv
(Figure 5B). Absence of TLR4 did not impact cytokine expression
in infections with H37Rv (Figure 5B). Furthermore, absence of
TLR4 also compromised iNOS gene expression (Figure 5B) and
protein (Figure 5C) during the infection with Mtb strain 02-171.
This finding may explain the inability of TLR42/2mice to control
Mtb strain 02-171 infection to the same degree as BL6 WT mice
(Figure 5A). In all, our in vivo data further support that TLR4
activation by certain Mtb strains contributes to cytokine induction
in the lung of infected hosts and suggest a protective role for TLR4
limited to the innate immune response to a TLR4-activating strain
of Mtb.
Discussion
Infections by Mtb, which represent the second most common
infectious cause of mortality and morbidity worldwide, are
characterized by an intriguingly large spectrum of disease
outcomes dictated by both host and pathogen genetic factors
[2,3]. Also fascinating is the marked heterogeneity of the immune
response mounted by the host against Mtb strains of the 6
described lineages [2,7,44]. This topic is particularly relevant for
Mtb strains of the Bj lineage, due to its possible association with
disease severity [4,8]. In this study, we provide evidence that
differential innate recognition of Mtb strains stands as a relevant
molecular mechanism associated with heterogeneous innate
immune responses to different variants of this pathogen.
Several classes of PRRs are involved in the recognition of Mtb,
including TLRs, C-type lectin receptors (CLRs), and Nod-like
receptors (NLRs) [19]. Both MyD88 and CARD9 (the master
adaptors of TLR and CLR signaling, respectively) are central for
the development of protective immune responses to Mtb
[20,21,22,47]. Among the TLR family, TLR2, TLR4 and
TLR9 are important molecules for the recognition of Mtb bacilli
and their relevance during Mtb infection has been extensively
studied. However, several authors have reported opposing results
concerning the role of these receptors in Mtb infections, with mice
lacking individual TLRs presenting either increased [24,27,29,48]
or unaltered [23,26,28] susceptibility to Mtb infection. To
elucidate the possible joint action of these TLRs, studies were
also performed with double and triple knock-out mice [25,49].
Mice deficient for TLR2, 4 and 9 were shown to present a mild
phenotype and control Mtb replication [25,49], adding to the
puzzling set of data describing TLR function during Mtb infection.
Comparing a panel of Mtb strains of the Bj lineage to the
laboratory reference strain H37Rv, we demonstrate here that
although most Mtb strains (including the reference strains H37Rv
and HN878) were recognized by TLR2, Mtb strain 02-171 also
activated macrophages via TLR4. Recognition of Mtb mediated
by TLR4 was not associated with particular phylogeographical
groups within the Bj lineage, as strains within the same group (eg.
04-092 and 02-171 strains from Gr3) preferentially activated
different TLRs. However, such a scenario may be different if a
more high-resolution tool for phylogenetic analysis [50] is used.
TLR4 triggering was also not exclusive of the Bj lineage, as an
Euro-American Mtb strain (Harlingen) was predominantly recog-
nized by this TLR. Finally, the heterogeneity of the immune
response and the differential TLR recognition reported were also
not related to the profile of drug susceptibility of each strain [51].
TLR4 activation results in intracellular signals mediated by both
MyD88 and TRIF, whereas TLR2 signals depend on MyD88
alone [18]. As a result of TRIF-pathway activation, a signaling
complex involving IKK and TBK-1 is formed, which catalyze the
phosphorylation of IRF3 and induce its nuclear translocation,
leading to the transcription of ifnb [18]. Consistent with this,
secretion of IFN-b by Mtb-infected macrophages was only
observed for TLR4-activating strains (02-171 and Harlingen).
Taking into consideration a recent report showing that Mtb
activates the DNA-dependent cytosolic surveillance pathway in
macrophages, inducing signalling through Sting/TBK-1/IRF3
with consequent ifnb transcription [52], our data now suggest that
certain strains of Mtb are also able to enhance this ifnb
Figure 3. Mtb strain Harlingen preferentially activates macro-
phages via TLR4. BMDM generated from WT (black bars), TLR22/2
(grey bars) or TLR42/2 (white bars) mice were infected with Mtb strain
Harlingen (moi of 2) and cytokine secretion measured as in Figure 1B.
Each bar represents Mean6SEM of triplicate wells. The statistics
analysis, determined by the Student’s t-test, refers to differences
between TLR22/2 or TLR42/2 and WT macrophages (*,p#0.05;
**,p#0.01; ***,p#0.001). The data are representative of three indepen-
dent experiments.
doi:10.1371/journal.pone.0067277.g003
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Figure 4. Mtb Bj strain 02-171 is more virulent during the innate immune response than H37Rv. (A) WT mice were intranasally infected
with Mtb strains H37Rv (white bars) or 02-171 (black bars) and at the indicated time points post-infection, lung cell suspensions were prepared,
diluted and plated into 7H11 agar to determine the number of mycobacterial CFUs in the lung. The bacterial burden 24 h post-infection was
Log10(CFU) 2.6760.57 and Log10(CFU) 2.4560.76 (Mean6SEM for 6 animals per strain) for Mtb strains H37Rv or 02-171 infected mice, respectively.
(B) WT mice were infected as before and, at the indicated time points post-infection, sections were prepared from formalin-fixed lungs. HE stained
tissue was blindly analysed and lung inflammation scored for each animal within the group (6 animals). Inflammation scores were: absent = 0;
mild = 1; abundant = 2; severe = 3; exacerbated= 4. (C) WT mice were infected with Mtb strains H37Rv (open circles) or 02-171 (close circles), RNA
extracted from the lung tissue and the expression of TNF, IFN-b, IFN-c and iNOS analyzed by quantitative real-time PCR and normalized to the
expression of ubiquitin. Data represented for day 0 correspond to uninfected animals. For A, B and C data points show the Mean6SEM for 5 mice per
group and the significance was determined by the Student’s t-test (*,p#0.05; **,p#0.01; ***,p#0.001) for each time point, between Mtb strains 02-
171 and H37Rv. The data are representative of three (A and B) or two (C) independent experiments. (D) Kaplan-Meier survival analysis of WT (solid
lines) or Rag22/2 (dashed lines) mice infected intranasally with Mtb strains H37Rv (open circles) or 02-171 (close circles). H37Rv-infected mice showed
improved survival (49 days vs 33 days with 02-171-infected mice), as calculated by log-rank test (***,p#0.0001). WT animals infected in parallel
survived up to day 200 post-infection. The data are representative of two independent experiments. (E) WT or Rag22/2 mice were infected with Mtb
strains H37Rv or 02-171 and lung CFU numbers determined on days 18 and 30 post-infection as indicated before. Data points show the Mean6SEM
for 6 mice per group. The statistics analysis between the different groups was determined by the Student’s t-test (**,p#0.01; ***,p#0.001).
doi:10.1371/journal.pone.0067277.g004
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transcription via TLR4 activation. This finding may be relevant as
type I IFN and IFN-inducible genes constitute a molecular
signature associated with active pulmonary Mtb infection in
humans [53]. Although the role of type I IFN during Mtb infection
remains unclear [15,54,55], mice lacking type I IFN receptor
present decreased bacterial burden and late mortality upon Mtb
infection [15,52,54,56]. Moreover, the virulence of certain Mtb
strains was suggested to be correlated with their ability to induce
type I IFN production in vivo [15,54]. Our findings showing that
Mtb strain 02-171 (a TLR4-activating and type I IFN inducer) was
more virulent during the innate phase of the immune response
than H37Rv in mice are in line with these observations.
Nevertheless, in the absence of TLR4 we found a further increase
on the lung bacterial burden of mice infected with Mtb strain 02-
171, despite the lower induction of IFN-b expression. Also, Mtb
strain Harlingen, another TLR4 activating strain, showed a degree
of virulence comparable to H37Rv (Fig. S2B), pointing to the fact
that the mechanisms underlying differences in virulence during the
innate phase of the immune response are most likely multifactorial.
On one hand, differences in virulence may result from the balance
of cytokine responses induced by different strains. Indeed, Mtb
strain 02-171 induced higher levels of both pro- and anti-
inflammatory cytokines in the lung of infected animals, a balance
that may favor susceptibility during the innate phase of the
immune response. This balance was altered in the absence of
TLR4, where we observed a decrease in the overall cytokine
expression and in the expression and production of iNOS,
accompanying an increase in bacterial burden. On the other
hand, it is also possible that Mtb strain 02-171 shows a higher
resistance to host innate killing mechanisms, thus escaping them
and growing faster during the early phases of infection.
Our data suggest a possible dual role for TLR4 during infection
with certain strains of Mtb, since its activation not only induced
type I IFN, that may result in increased susceptibility
[15,52,54,56], but simultaneously induced the expression of
protective cytokines (e.g. TNF) and of iNOS, a molecule known
to be important for the control infection [57]. The participation of
TLR4 appeared to predominate in the innate phases of the
immune response. In contrast, the adaptive immunity was equally
effective either in the presence or absence of TLR4, causing a
significant reduction in CFU numbers observed after day 18 of
infection. This finding is interesting, as previous reports on the role
of TLR2 or TLR9 in Mtb infections evidenced a more
pronounced effect in later stages of infection, in terms of
granuloma formation [24,27,29,48], Th17 cell maintenance
[24,27,29,48] or Th1 cell differentiation [24,27,29,48]. Of note,
in the absence of TLR4 we still observed cytokine expression in
the lungs of mice infected with Mtb strain 02-171, suggesting that
Figure 5. TLR4 deficiency compromises innate protection
against Mtb infection by a TLR4-activating Mtb Bj strain. (A)
WT (circles) or TLR42/2 (diamonds) mice were infected intranasally with
Mtb strains H37Rv (left panel) or 02-171 (right panel) and at the
indicated time points the bacterial burden in the lungs determined as in
Figure 4A. The bacterial burden 24 h post-infection was Log10(CFU)
2.2560.68 and Log10(CFU) 2.1060.28 for WT or TLR42/2 infected with
Mtb strain H37Rv (Mean6SEM for 6 animals per strain). As for Mtb strain
02-171 infected mice, the bacterial burden 24 h post-infection was
Log10(CFU) 2.4860.61 and Log10(CFU) 2.5860.43 for WT or TLR42/2
(Mean6SEM for 6 animals per strain), respectively. (B) WT (circles) or
TLR42/2 (diamonds) mice were infected with Mtb strains H37Rv (left
panel) or 02-171 (right panel), and the expression of TNF, IFN-c, IFN-b
and iNOS analyzed by quantitative real-time PCR and normalized to the
expression of ubiquitin. Data represented for day 0 correspond to
uninfected animals. For A and B, data points show the Mean6SEM for
six mice per group and the significance was determined by the
Student’s t-test (*,p#0.05; **,p#0.01; ***,p#0.001) for each time point
and each Mtb strain between WT and TLR42/2 mice. The data are
representative of two independent experiments. (C) The production of
iNOS in the lung tissue of WT or TLR42/2 infected mice was determined
for day 30 post-infection by immunofluorescence. Represented are 106
magnifications of one animal out of 5 per group.
doi:10.1371/journal.pone.0067277.g005
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other PRRs, and/or that innate cells other than macrophages,
harboring a different set of PRRs, must operate in vivo.
Despite the faster growth observed for Mtb strain 02-171 during
the initial phase of the in vivo infection, at around day 30 we
observed a sharp decrease on the lung bacterial load. This is an
atypical observation for Mtb infections and the underlying cellular
and molecular mechanisms are currently under investigation. It is
possible that this strain of Mtb induces a T cell response with
specific characteristics and dynamics that transiently lead to a
better control of bacterial burden in the lung, thus allowing killing
of the mycobacteria. In line with this hypothesis, our findings show
that in a system where the acquired immune response fails, such as
the Rag22/2, Mtb strain 02-171 is more virulent and lethal than
the reference strain H37Rv.
Our study brings forth a compelling amount of evidence
showing that Mtb strains are recognized differently via TLR2 or
TLR4 with possible implications on the in vivo innate immune
responses to Mtb. It would be of the utmost interest to now pursue
our findings in an effort to uncover the molecule(s) present in Mtb
strain 02-171 that is/are able to activate TLR4. It will be also of
interest to increase the number of strains tested in order to
investigate how they cluster according to their ability to
preferentially activate TLR2 vs TLR4. Our results may, at least
in part, explain the discrepant data obtained by different groups
addressing the association of TLR polymorphisms to TB
susceptibility, highlighting the relevance of also investigating the
relation between the infecting strain and the studied TLR
polymorphism.
Supporting Information
Figure S1 Differential TLR recognition of Mtb strains
determines the cytokine transcription profile of infected
macrophages and is independent of the moi. (A) WT
BMDM were infected with two independent stocks of Mtb strains
H37Rv (stocks 1 and 2) or 02-171 (stocks A and B) with a moi of 2.
Six hours post-infection the supernatant of the infected BMDM
was harvested and the amount of secreted TNF measured by
immunoassay. Each bar represents Mean6SEM of triplicate wells.
The statistics analysis was determined by the Student’s t-test
(**,p#0.01; ***,p#0.001). (B) BMDM were infected with the
indicated Mtb strains with a moi of 2, for 4 h. After this period of
time, the wells were extensively washed, the cells lysed and the
bacterial burden determined by CFU counting in 7H11 agar
plates. Each bar represents Mean6SEM of six wells. (C) BMDM
generated from WT (close circles), TLR22/2 (open squares) or
TLR42/2 (open diamonds) mice were infected with Mtb strains
H37Rv or 02-171 with a moi of 2 and at specific time points post-
infection RNA was extracted and the expression of TNF, IL-6, IL-
10 and IFN-b analyzed by quantitative real-time PCR and
normalized to the expression of ubiquitin. Each time point
represents Mean6SEM of triplicate wells. The statistics analysis,
determined by the Student’s t-test, refers to differences between
TLR22/2 or TLR42/2 and WT macrophages for each strain
(*,p#0.05; **,p#0.01; ***,p#0.001). (D) WT (close circles) or
TLR42/2 (open diamonds) BMDM were infected with Mtb strain
02-171 at different moi. Six hours post-infection the supernatant of
the infected cultures was harvested and the amount of secreted
TNF measured by immunoassay. Each moi analysed represents
Mean6SEM of triplicate wells. The statistics analysis was
determined by the Student’s t-test (***,p#0.001).
(TIF)
Figure S2 (A) Deficiency of TLR2 does not compromise
the control of infection with Mtb strains H37Rv or 02-
171. WT (circles) or TLR22/2 (squares) mice were infected
intranasally with Mtb strains H37Rv or Bj 02-171 and at the
indicated time points, lung cell suspensions were prepared, diluted
and plated to determine the number of mycobacterial CFUs. Data
points show the Mean6SEM for six mice per group. The values
were found not to be significantly different as determined by the
Student’s t-test. The data are representative of two independent
experiments. (B) Mtb strain 02-171 presents an increased
in vivo growth as compared to H37Rv or Harlingen. WT
mice were infected intranasally with Mtb strains H37Rv (open
circles), 02-171 (close circles) or Harlingen (triangles) and at the
indicated time points, lung cell suspensions were prepared, diluted
and plated to determine the number of mycobacterial CFUs. Data
points show the Mean6SEM for six mice per group. The bacterial
burden 24 h post-infection was Log10(CFU) 2.6760.57,
Log10(CFU) 2.4560.76 and Log10(CFU) 2.5160.46 (Mean6-
SEM for 6 (H37Rv or 02-171) or 5 (Harlingen) animals) for Mtb
strains H37Rv, 02-171 or Harlingen infected mice, respectively.




The authors are grateful to Drs Anne O’Garra, Rui Appelberg and
Margarida Correia-Neves for helpful discussions and to Dr Paul S. Redford
for critically reading the manuscript. The authors thank the personnel at
the ICVS animal house facility for excellent animal husbandry.
Author Contributions
Conceived and designed the experiments: JC LMT JP FR AGC MS.
Performed the experiments: JC AC LMT CS JS NSO ALS. Analyzed the
data: JC AC LMT SS GK JP FR AGC MS. Contributed reagents/
materials/analysis tools: SS GK. Wrote the paper: JC LMT AGC MS.
References
1. WHO (2011) Global Tuberculosis Control - Surveillance. Planning, Financing:
WHO Report. World Health Organization.
2. Kirschner DE, Young D, Flynn JL (2010) Tuberculosis: global approaches to a
global disease. Curr Opin Biotechnol 21: 524–531.
3. Lin PL, Flynn JL (2010) Understanding latent tuberculosis: a moving target.
J Immunol 185: 15–22.
4. Coscolla M, Gagneux S (2010) Does M. tuberculosis genomic diversity explain
disease diversity? Drug Discov Today Dis Mech 7: e43-e59.
5. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, et al. (2006)
Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl
Acad Sci U S A 103: 2869–2873.
6. Krishnan N, Malaga W, Constant P, Caws M, Tran TH, et al. (2011)
Mycobacterium tuberculosis lineage influences innate immune response and
virulence and is associated with distinct cell envelope lipid profiles. PLoS One 6:
e23870.
7. Portevin D, Gagneux S, Comas I, Young D (2011) Human macrophage
responses to clinical isolates from the Mycobacterium tuberculosis complex
discriminate between ancient and modern lineages. PLoS Pathog 7: e1001307.
8. Parwati I, van Crevel R, van Soolingen D (2010) Possible underlying
mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing
genotype strains. Lancet Infect Dis 10: 103–111.
9. Abebe F, Bjune G (2006) The emergence of Beijing family genotypes of
Mycobacterium tuberculosis and low-level protection by bacille Calmette-
Guerin (BCG) vaccines: is there a link? Clin Exp Immunol 145: 389–397.
10. Hanekom M, Gey van Pittius NC, McEvoy C, Victor TC, Van Helden PD, et
al. (2011) Mycobacterium tuberculosis Beijing genotype: a template for success.
Tuberculosis (Edinb) 91: 510–523.
11. Aguilar D, Hanekom M, Mata D, Gey van Pittius NC, van Helden PD, et al.
(2010) Mycobacterium tuberculosis strains with the Beijing genotype demon-
Mtb Has TLR2- and TLR4-Activating Strains
PLOS ONE | www.plosone.org 9 June 2013 | Volume 8 | Issue 6 | e67277
strate variability in virulence associated with transmission. Tuberculosis (Edinb)
90: 319–325.
12. Dormans J, Burger M, Aguilar D, Hernandez-Pando R, Kremer K, et al. (2004)
Correlation of virulence, lung pathology, bacterial load and delayed type
hypersensitivity responses after infection with different Mycobacterium tuber-
culosis genotypes in a BALB/c mouse model. Clin Exp Immunol 137: 460–468.
13. Dunn PL, North RJ (1995) Virulence ranking of some Mycobacterium
tuberculosis and Mycobacterium bovis strains according to their ability to
multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect
Immun 63: 3428–3437.
14. Lopez B, Aguilar D, Orozco H, Burger M, Espitia C, et al. (2003) A marked
difference in pathogenesis and immune response induced by different
Mycobacterium tuberculosis genotypes. Clin Exp Immunol 133: 30–37.
15. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, et al. (2001) Virulence
of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure
to induce Th1 type immunity and is associated with induction of IFN-alpha/
beta. Proc Natl Acad Sci U S A 98: 5752–5757.
16. Bhatt K, Salgame P (2007) Host innate immune response to Mycobacterium
tuberculosis. J Clin Immunol 27: 347–362.
17. Cooper AM (2009) Cell-mediated immune responses in tuberculosis. Annu Rev
Immunol 27: 393–422.
18. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate
immunity: update on Toll-like receptors. Nat Immunol 11: 373–384.
19. Kleinnijenhuis J, Oosting M, Joosten LA, Netea MG, Van Crevel R (2011)
Innate immune recognition of Mycobacterium tuberculosis. Clin Dev Immunol
2011: 405310.
20. Fremond CM, Yeremeev V, Nicolle DM, Jacobs M, Quesniaux VF, et al. (2004)
Fatal Mycobacterium tuberculosis infection despite adaptive immune response
in the absence of MyD88. J Clin Invest 114: 1790–1799.
21. Scanga CA, Bafica A, Feng CG, Cheever AW, Hieny S, et al. (2004) MyD88-
deficient mice display a profound loss in resistance to Mycobacterium
tuberculosis associated with partially impaired Th1 cytokine and nitric oxide
synthase 2 expression. Infect Immun 72: 2400–2404.
22. Shi S, Nathan C, Schnappinger D, Drenkow J, Fuortes M, et al. (2003) MyD88
primes macrophages for full-scale activation by interferon-gamma yet mediates
few responses to Mycobacterium tuberculosis. J Exp Med 198: 987–997.
23. Teixeira-Coelho M, Cruz A, Carmona J, Sousa C, Ramos-Pereira D, et al.
(2011) TLR2 deficiency by compromising p19 (IL-23) expression limits Th 17
cell responses to Mycobacterium tuberculosis. Int Immunol 23: 89–96.
24. Drennan MB, Nicolle D, Quesniaux VJ, Jacobs M, Allie N, et al. (2004) Toll-like
receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection.
Am J Pathol 164: 49–57.
25. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, et al. (2005) TLR9
regulates Th1 responses and cooperates with TLR2 in mediating optimal
resistance to Mycobacterium tuberculosis. J Exp Med 202: 1715–1724.
26. Sugawara I, Yamada H, Li C, Mizuno S, Takeuchi O, et al. (2003)
Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol
Immunol 47: 327–336.
27. Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, et al. (2002) Toll-like
receptor 4 expression is required to control chronic Mycobacterium tuberculosis
infection in mice. J Immunol 169: 3155–3162.
28. Kamath AB, Alt J, Debbabi H, Behar SM (2003) Toll-like receptor 4-defective
C3H/HeJ mice are not more susceptible than other C3H substrains to infection
with Mycobacterium tuberculosis. Infect Immun 71: 4112–4118.
29. Reiling N, Holscher C, Fehrenbach A, Kroger S, Kirschning CJ, et al. (2002)
Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen
recognition in resistance to airborne infection with Mycobacterium tuberculosis.
J Immunol 169: 3480–3484.
30. Ogus AC, Yoldas B, Ozdemir T, Uguz A, Olcen S, et al. (2004) The
Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis
disease. Eur Respir J 23: 219–223.
31. Thuong NT, Hawn TR, Thwaites GE, Chau TT, Lan NT, et al. (2007) A
polymorphism in human TLR2 is associated with increased susceptibility to
tuberculous meningitis. Genes Immun 8: 422–428.
32. Velez DR, Wejse C, Stryjewski ME, Abbate E, Hulme WF, et al. (2010) Variants
in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in
Caucasians, African-Americans, and West Africans. Hum Genet 127: 65–73.
33. Yim JJ, Lee HW, Lee HS, Kim YW, Han SK, et al. (2006) The association
between microsatellite polymorphisms in intron II of the human Toll-like
receptor 2 gene and tuberculosis among Koreans. Genes Immun 7: 150–155.
34. Biswas D, Gupta SK, Sindhwani G, Patras A (2009) TLR2 polymorphisms,
Arg753Gln and Arg677Trp, are not associated with increased burden of
tuberculosis in Indian patients. BMC Res Notes 2: 162.
35. Ma MJ, Xie LP, Wu SC, Tang F, Li H, et al. (2010) Toll-like receptors, tumor
necrosis factor-alpha, and interleukin-10 gene polymorphisms in risk of
pulmonary tuberculosis and disease severity. Hum Immunol 71: 1005–1010.
36. Selvaraj P, Harishankar M, Singh B, Jawahar MS, Banurekha VV (2010) Toll-
like receptor and TIRAP gene polymorphisms in pulmonary tuberculosis
patients of South India. Tuberculosis (Edinb) 90: 306–310.
37. Xue Y, Zhao ZQ, Wang HJ, Jin L, Liu CP, et al. (2010) Toll-like receptors 2 and
4 gene polymorphisms in a southeastern Chinese population with tuberculosis.
Int J Immunogenet 37: 135–138.
38. Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, et al. (2007) A
Mal functional variant is associated with protection against invasive pneumo-
coccal disease, bacteremia, malaria and tuberculosis. Nat Genet 39: 523–528.
39. Najmi N, Kaur G, Sharma SK, Mehra NK (2010) Human Toll-like receptor 4
polymorphisms TLR4 Asp299Gly and Thr399Ile influence susceptibility and
severity of pulmonary tuberculosis in the Asian Indian population. Tissue
Antigens 76: 102–109.
40. Newport MJ, Allen A, Awomoyi AA, Dunstan SJ, McKinney E, et al. (2004) The
toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or
susceptibility to pulmonary tuberculosis in The Gambia. Tuberculosis (Edinb)
84: 347–352.
41. Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NT, et al. (2008) The
influence of host and bacterial genotype on the development of disseminated
disease with Mycobacterium tuberculosis. PLoS Pathog 4: e1000034.
42. Tsolaki AG, Gagneux S, Pym AS, Goguet de la Salmoniere YO, Kreiswirth BN,
et al. (2005) Genomic deletions classify the Beijing/W strains as a distinct genetic
lineage of Mycobacterium tuberculosis. J Clin Microbiol 43: 3185–3191.
43. Saraiva M, Christensen JR, Tsytsykova AV, Goldfeld AE, Ley SC, et al. (2005)
Identification of a macrophage-specific chromatin signature in the IL-10 locus.
J Immunol 175: 1041–1046.
44. Wang C, Peyron P, Mestre O, Kaplan G, van Soolingen D, et al. (2010) Innate
immune response to Mycobacterium tuberculosis Beijing and other genotypes.
PLoS One 5: e13594.
45. Reiley WW, Calayag MD, Wittmer ST, Huntington JL, Pearl JE, et al. (2008)
ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis
infection are initiated in the mediastinal lymph nodes. Proc Natl Acad Sci U S A
105: 10961–10966.
46. Wolf AJ, Desvignes L, Linas B, Banaiee N, Tamura T, et al. (2008) Initiation of
the adaptive immune response to Mycobacterium tuberculosis depends on
antigen production in the local lymph node, not the lungs. J Exp Med 205: 105–
115.
47. Dorhoi A, Desel C, Yeremeev V, Pradl L, Brinkmann V, et al. (2010) The
adaptor molecule CARD9 is essential for tuberculosis control. J Exp Med 207:
777–792.
48. Branger J, Leemans JC, Florquin S, Weijer S, Speelman P, et al. (2004) Toll-like
receptor 4 plays a protective role in pulmonary tuberculosis in mice. Int
Immunol 16: 509–516.
49. Holscher C, Reiling N, Schaible UE, Holscher A, Bathmann C, et al. (2008)
Containment of aerogenic Mycobacterium tuberculosis infection in mice does
not require MyD88 adaptor function for TLR2, -4 and -9. Eur J Immunol 38:
680–694.
50. Mestre O, Luo T, Dos Vultos T, Kremer K, Murray A, et al. (2011) Phylogeny
of Mycobacterium tuberculosis Beijing strains constructed from polymorphisms
in genes involved in DNA replication, recombination and repair. PLoS One 6:
e16020.
51. Ghebremichael S, Groenheit R, Pennhag A, Koivula T, Andersson E, et al.
(2010) Drug resistant Mycobacterium tuberculosis of the Beijing genotype does
not spread in Sweden. PLoS One 5: e10893.
52. Manzanillo PS, Shiloh MU, Portnoy DA, Cox JS (2012) Mycobacterium
tuberculosis activates the DNA-dependent cytosolic surveillance pathway within
macrophages. Cell Host Microbe 11: 469–480.
53. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An
interferon-inducible neutrophil-driven blood transcriptional signature in human
tuberculosis. Nature 466: 973–977.
54. Manca C, Tsenova L, Freeman S, Barczak AK, Tovey M, et al. (2005)
Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and
increase expression of negative regulators of the Jak-Stat pathway. J Interferon
Cytokine Res 25: 694–701.
55. Ordway D, Henao-Tamayo M, Harton M, Palanisamy G, Troudt J, et al. (2007)
The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent
TH1 response followed by rapid down-regulation. J Immunol 179: 522–531.
56. Desvignes L, Wolf AJ, Ernst JD (2012) Dynamic roles of type I and type II IFNs
in early infection with Mycobacterium tuberculosis. J Immunol 188: 6205–6215.
57. North RJ, Jung YJ (2004) Immunity to tuberculosis. Annu Rev Immunol 22:
599–623.
Mtb Has TLR2- and TLR4-Activating Strains
PLOS ONE | www.plosone.org 10 June 2013 | Volume 8 | Issue 6 | e67277
